» Articles » PMID: 23593438

Variable VlsE is Critical for Host Reinfection by the Lyme Disease Spirochete

Overview
Journal PLoS One
Date 2013 Apr 18
PMID 23593438
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Many pathogens make use of antigenic variation as a way to evade the host immune response. A key mechanism for immune evasion and persistent infection by the Lyme disease spirochete, Borrelia burgdorferi, is antigenic variation of the VlsE surface protein. Recombination results in changes in the VlsE surface protein that prevent recognition by VlsE-specific antibodies in the infected host. Despite the presence of a substantial number of additional proteins residing on the bacterial surface, VlsE is the only known antigen that exhibits ongoing variation of its surface epitopes. This suggests that B. burgdorferi may utilize a VlsE-mediated system for immune avoidance of its surface antigens. To address this, the requirement of VlsE for host reinfection by the Lyme disease pathogen was investigated. Host-adapted wild type and VlsE mutant spirochetes were used to reinfect immunocompetent mice that had naturally cleared an infection with a VlsE-deficient clone. Our results demonstrate that variable VlsE is necessary for reinfection by B. burgdorferi, and this ability is directly related to evasion of the host antibody response. Moreover, the data presented here raise the possibility that VlsE prevents recognition of B. burgdorferi surface antigens from host antibodies. Overall, our findings represent a significant advance in our knowledge of immune evasion by B. burgdorferi, and provide insight to the possible mechanisms involved in VlsE-mediated immune avoidance.

Citing Articles

Breaking a barrier: In trans vlsE recombination and genetic manipulation of the native vlsE gene of the Lyme disease pathogen.

Singh P, Bankhead T PLoS Pathog. 2025; 21(1):e1012871.

PMID: 39792948 PMC: 11756760. DOI: 10.1371/journal.ppat.1012871.


Do white-footed mice, the main reservoir of the Lyme disease pathogen in the United States, clinically respond to the borrelial tenancy?.

Rogovskyy A, Pliasas V, Buhrer R, Lewy K, Wiener D, Jung Y Infect Immun. 2024; 92(12):e0038224.

PMID: 39535189 PMC: 11629617. DOI: 10.1128/iai.00382-24.


Meta-analysis of the Vmp-like sequences of Lyme disease : evidence for the evolution of an elaborate antigenic variation system.

Norris S, Brangulis K Front Microbiol. 2024; 15:1469411.

PMID: 39450289 PMC: 11499132. DOI: 10.3389/fmicb.2024.1469411.


Suppression of host humoral immunity by varies over the course of infection.

Williams M, Zhang Y, Pulse M, Berg R, Allen M Infect Immun. 2024; 92(4):e0001824.

PMID: 38514468 PMC: 11003232. DOI: 10.1128/iai.00018-24.


Subversion of the immune response of human pathogenic spirochetes.

Huang J, Chen J, Xie Y, Liu Z J Clin Lab Anal. 2022; 36(5):e24414.

PMID: 35403248 PMC: 9102653. DOI: 10.1002/jcla.24414.


References
1.
Kenedy M, Lenhart T, Akins D . The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol. 2012; 66(1):1-19. PMC: 3424381. DOI: 10.1111/j.1574-695X.2012.00980.x. View

2.
Wilske B, Preac-Mursic V, Jauris S, Hofmann A, Pradel I, Soutschek E . Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun. 1993; 61(5):2182-91. PMC: 280819. DOI: 10.1128/iai.61.5.2182-2191.1993. View

3.
Purser J, Norris S . Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci U S A. 2000; 97(25):13865-70. PMC: 17667. DOI: 10.1073/pnas.97.25.13865. View

4.
Tilly K, Bestor A, Dulebohn D, Rosa P . OspC-independent infection and dissemination by host-adapted Borrelia burgdorferi. Infect Immun. 2009; 77(7):2672-82. PMC: 2708573. DOI: 10.1128/IAI.01193-08. View

5.
Tilly K, Krum J, Bestor A, Jewett M, Grimm D, Bueschel D . Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun. 2006; 74(6):3554-64. PMC: 1479285. DOI: 10.1128/IAI.01950-05. View